Form 4 holding
10%+ Owner
SOLESENCE, INC.
- Security class
- Common Stock
- Shares / value
- 30,373,270
- Estimated value
- $127,567,734
- Report date
- 29 May 2025
- Price
- $4.20
- Ownership
- By Strandler, LLC
Bradford T. Whitmore
Insider Reports History
- Reporting-owner location
- Skokie, IL
- Latest reporting-owner signature
-
Bradford T. Whitmore
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Bradford T. Whitmore
Form 4 holding
10%+ Owner
SOLESENCE, INC.
- Security class
- Common Stock
- Shares / value
- 18,669,879
- Estimated value
- $78,413,491
- Report date
- 29 May 2025
- Price
- $4.20
- Ownership
- By Whitmore Holdings, LLC
Form 4 holding
Director, 10%+ Owner
ULTRALIFE CORP
- Security class
- Common Stock
- Shares / value
- 4,452,283
- Estimated value
- $29,028,885
- Report date
- 21 May 2026
- Price
- $6.52
- Ownership
- By SUNRAY I, LLC
Form 4 holding
Director, 10%+ Owner
ULTRALIFE CORP
- Security class
- Common Stock
- Shares / value
- 2,050,637
- Estimated value
- $13,972,425
- Report date
- 26 May 2026
- Price
- $6.81
- Ownership
- By Whitmore Holdings, LLC
Form 4 holding
10%+ Owner
Clearside Biomedical, Inc.
- Security class
- Common Stock
- Shares / value
- 4,495,034
- Estimated value
- $6,068,296
- Report date
- 07 Feb 2024
- Price
- $1.35
- Ownership
- Direct
Form 4 holding
10%+ Owner
Clearside Biomedical, Inc.
- Security class
- Common Stock
- Shares / value
- 2,350,152
- Estimated value
- $3,172,705
- Report date
- 07 Feb 2024
- Price
- $1.35
- Ownership
- by Grace Brothers, LP
Form 4 holding
10%+ Owner
SOLESENCE, INC.
- Security class
- Common Stock
- Shares / value
- 675,515
- Estimated value
- $2,634,508
- Report date
- 29 May 2025
- Price
- $3.90
- Ownership
- By Grace Investments, LP
Form 4 holding
Director, 10%+ Owner
ULTRALIFE CORP
- Security class
- Common Stock
- Shares / value
- 205,915
- Estimated value
- $1,342,565
- Report date
- 21 May 2026
- Price
- $6.52
- Ownership
- Direct
Form 4 holding
10%+ Owner
SOLESENCE, INC.
- Security class
- Common Stock
- Shares / value
- 108,141
- Estimated value
- $421,749
- Report date
- 29 May 2025
- Price
- $3.90
- Ownership
- Direct
Form 4 holding
10%+ Owner
Clearside Biomedical, Inc.
- Security class
- Warrant
- Shares / value
- 444,444
- Estimated value
- Report date
- 07 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Bradford T. Whitmore
4
ULBI
ULTRALIFE CORP
- Report period
- 21 May 2026
- Transactions
- 3
- Transaction value
- +$715,314
- Accepted by SEC
- 26 May 2026, 16:18
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 12 Mar 2026
- Transactions
- 3
- Transaction value
- +$1,196,909
- Accepted by SEC
- 16 Mar 2026, 16:25
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 31 Dec 2025
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 05 Jan 2026, 19:56
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 12 Dec 2025
- Transactions
- 3
- Transaction value
- +$300,902
- Accepted by SEC
- 16 Dec 2025, 16:32
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 19 Nov 2025
- Transactions
- 1
- Transaction value
- +$267,915
- Accepted by SEC
- 21 Nov 2025, 16:01
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 19 Aug 2025
- Transactions
- 3
- Transaction value
- +$387,100
- Accepted by SEC
- 21 Aug 2025, 16:58
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 13 Jun 2025
- Transactions
- 1
- Transaction value
- +$76,392
- Accepted by SEC
- 13 Jun 2025, 16:19
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
SLSN
SOLESENCE, INC.
- Report period
- 29 May 2025
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 02 Jun 2025, 16:01
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 23 May 2025
- Transactions
- 1
- Transaction value
- +$64,778
- Accepted by SEC
- 28 May 2025, 16:16
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 13 May 2025
- Transactions
- 3
- Transaction value
- +$148,475
- Accepted by SEC
- 15 May 2025, 16:25
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 03 Sep 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 03 Sep 2024, 16:46
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 03 Sep 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 03 Sep 2024, 16:33
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 25 Jun 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 26 Jun 2024, 16:21
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 01 Mar 2024
- Transactions
- 1
- Transaction value
- +$6,000,000
- Accepted by SEC
- 05 Mar 2024, 16:06
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 08 Feb 2024
- Transactions
- 4
- Transaction value
- +$1,529,946
- Accepted by SEC
- 12 Feb 2024, 16:58
- Role
- 10%+ Owner
- Next action
- Open filing details
4
CLSD
Clearside Biomedical, Inc.
- Report period
- 07 Feb 2024
- Transactions
- 2
- Transaction value
- +$599,999
- Accepted by SEC
- 09 Feb 2024, 13:00
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 06 Dec 2023
- Transactions
- 2
- Transaction value
- +$110,943
- Accepted by SEC
- 08 Dec 2023, 16:14
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 27 Nov 2023
- Transactions
- 3
- Transaction value
- +$180,651
- Accepted by SEC
- 29 Nov 2023, 16:19
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 30 Oct 2023
- Transactions
- 3
- Transaction value
- +$98,991
- Accepted by SEC
- 01 Nov 2023, 16:44
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
CLSD
Clearside Biomedical, Inc.
- Report period
- 30 Oct 2023
- Transactions
- 3
- Transaction value
- +$99,849
- Accepted by SEC
- 01 Nov 2023, 16:24
- Role
- 10%+ Owner
- Next action
- Open filing details
3
CLSD
Clearside Biomedical, Inc.
- Report period
- 27 Oct 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 01 Nov 2023, 16:04
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 13 Sep 2023
- Transactions
- 3
- Transaction value
- +$111,613
- Accepted by SEC
- 15 Sep 2023, 15:40
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 21 Aug 2023
- Transactions
- 3
- Transaction value
- +$78,899
- Accepted by SEC
- 23 Aug 2023, 16:26
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 12 Jun 2023
- Transactions
- 3
- Transaction value
- +$398,096
- Accepted by SEC
- 14 Jun 2023, 16:29
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 02 Jun 2023
- Transactions
- 1
- Transaction value
- +$26,242
- Accepted by SEC
- 05 Jun 2023, 15:22
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 30 May 2023
- Transactions
- 3
- Transaction value
- +$146,392
- Accepted by SEC
- 01 Jun 2023, 16:55
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 30 May 2023
- Transactions
- 3
- Transaction value
- +$19,328
- Accepted by SEC
- 01 Jun 2023, 16:34
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 17 May 2023
- Transactions
- 3
- Transaction value
- +$56,199
- Accepted by SEC
- 19 May 2023, 16:16
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 09 May 2023
- Transactions
- 3
- Transaction value
- +$116,783
- Accepted by SEC
- 11 May 2023, 16:51
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 09 Mar 2023
- Transactions
- 3
- Transaction value
- +$121,893
- Accepted by SEC
- 13 Mar 2023, 16:37
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4/A
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 15 Dec 2022
- Transactions
- 1
- Transaction value
- +$330,597
- Accepted by SEC
- 16 Dec 2022, 09:17
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 14 Dec 2022
- Transactions
- 3
- Transaction value
- +$151,962
- Accepted by SEC
- 16 Dec 2022, 12:29
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 06 Dec 2022
- Transactions
- 3
- Transaction value
- +$278,729
- Accepted by SEC
- 08 Dec 2022, 16:09
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 06 Dec 2022
- Transactions
- 3
- Transaction value
- +$212,867
- Accepted by SEC
- 08 Dec 2022, 15:46
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 16 Nov 2022
- Transactions
- 3
- Transaction value
- +$185,498
- Accepted by SEC
- 18 Nov 2022, 15:28
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 17 Aug 2022
- Transactions
- 2
- Transaction value
- +$157,628
- Accepted by SEC
- 19 Aug 2022, 16:03
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 02 Aug 2022
- Transactions
- 3
- Transaction value
- +$467,486
- Accepted by SEC
- 04 Aug 2022, 16:54
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 06 Jun 2022
- Transactions
- 2
- Transaction value
- +$219,252
- Accepted by SEC
- 08 Jun 2022, 16:06
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 24 Feb 2022
- Transactions
- 3
- Transaction value
- +$244,690
- Accepted by SEC
- 28 Feb 2022, 15:43
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 21 Dec 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 23 Dec 2021, 15:28
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 17 Dec 2021
- Transactions
- 1
- Transaction value
- +$296,624
- Accepted by SEC
- 20 Dec 2021, 15:11
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
CLSD
Clearside Biomedical, Inc.
- Report period
- 30 Aug 2021
- Transactions
- 3
- Transaction value
- -$2,920,427
- Accepted by SEC
- 01 Sep 2021, 16:46
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ULBI
ULTRALIFE CORP
- Report period
- 02 Aug 2021
- Transactions
- 3
- Transaction value
- +$199,271
- Accepted by SEC
- 04 Aug 2021, 15:55
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
SLSN
NANOPHASE TECHNOLOGIES Corp
- Report period
- 07 May 2021
- Transactions
- 2
- Transaction value
- +$1,615,289
- Accepted by SEC
- 11 May 2021, 16:37
- Role
- 10%+ Owner
- Next action
- Open filing details